Articles

Spanish Political Divisions Threaten Policy-Making Process

Country Risk / Spain / Fri 19 Jan, 2024

Key View

  • We anticipate that Prime Minister Pedro Sanchez and his government will continue to face difficulties passing legislation as ideological differences and the lack of a majority obstructs the policymaking process.
  • Podemos’ exit from the government means that policy in areas such as labour will be especially complicated.
  • The divisions
Read More

Singapore Not Likely To See Another Bumper Year For FDI

Country Risk / Singapore / Thu 18 Jan, 2024

Key View

  • We expect inward FDI to fall below 30% of GDP in 2023 and 2024.
  • A jump in retained earnings were behind the FDI increase in 2021 and 2022, and they notably did little to boost economic growth in Singapore.
  • The expected reduction in inward FDI will not pose risks to Singapore’s external balance, given ample foreign reserves and
Read More

Quick View: Lupin Achieves Three New Generic Approvals In The US Highlighting Continued Interest In Expanding Generics Portfolio

Pharmaceuticals / United States / Thu 18 Jan, 2024

The Latest: On January 14 2024, Lupin announced that it had received US FDA approval to market a generic version of propranolol hydrochloride extended-release capsules, used in the treatment of migraine and hypertension. The approval is significant as Lupin can offer a more affordable alternative to ANI Pharmaceuticals' Inderal LA extended

Read More
Download Indicator Summary
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Clearbit Form
 

Thank you. Your download link will be emailed to you shortly.